Treatment for anemia due to CKD
Aranesp (aranesp.com) scores 69 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, in the 20th percentile of 10846 Healthcare brands.
Aranesp (darbepoetin alfa) is a pharmaceutical product developed by Amgen used to treat anemia caused by chronic kidney disease (CKD). It belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). The Aranesp website provides information primarily for nephrologists and other healthcare professionals about using this therapy to manage CKD-related anemia in their patients, emphasizing clinical study data and Amgen's biotechnology background.
| Brand Name | Aranesp |
|---|---|
| Domain | aranesp.com |
| Industry | Healthcare |
| Parent Company / Owner | Amgen |
| Main Competitors | Epogen (74/100), Procrit (61/100), Mircera (74/100), Retacrit (66/100) |
Moz Domain Authority 34/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Aranesp appears on Wikipedia but without a dedicated company entity, so AI models can confuse it with similarly named subjects.
The homepage meta description reads "Learn about Amgen ESAs as a treatment for anemia due to chronic kidney disease (CKD) for nephrologists" (Meta description: 17 words (ideal length). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on Instagram; no detected presence on X (Twitter), LinkedIn, Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Aranesp?", Claude could identify the brand as of September 2026. Aranesp is the brand name for darbepoetin alfa, an injectable erythropoiesis-stimulating agent made by Amgen used to treat anemia caused by chronic kidney disease or chemotherapy. Best known for Treating anemia in chronic kidney disease and chemotherapy patients by stimulating red blood cell production.
When asked "Best brands similar to Aranesp?", Claude would recommend Aranesp as of September 2026. It's a well-known, widely prescribed erythropoiesis-stimulating drug, so it would naturally come up alongside similar treatments like Epogen or Procrit.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Aranesp's main competitors in Healthcare: Epogen (74/100), Procrit (61/100), Mircera (74/100), Retacrit (66/100).
Sources: Brand Analyzer scan
Aranesp is the brand name for darbepoetin alfa, a pharmaceutical product developed by Amgen. It is an erythropoiesis-stimulating agent (ESA) used to treat anemia caused by chronic kidney disease (CKD).
Sources: Aranesp official site
Aranesp has limited AI-search visibility, scoring 31/100 on Brand Analyzer's AI visibility composite (visibility 31, trust 19, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Aranesp official site
Aranesp offers darbepoetin alfa, an erythropoiesis-stimulating agent (ESA) indicated for the treatment of anemia due to chronic kidney disease. The website provides information about this product for healthcare professionals rather than offering multiple products or services.
Sources: Aranesp official site
Aranesp works as an ESA to stimulate red blood cell production in patients whose anemia is caused by chronic kidney disease. The Aranesp website provides nephrologists and other healthcare professionals with clinical information about using the drug as a treatment option for this condition.
Sources: Aranesp official site
Aranesp scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Aranesp official site
Aranesp can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Aranesp official site
Aranesp is intended for use by nephrologists and other healthcare professionals who treat patients with anemia caused by chronic kidney disease. These professionals reference the site for clinical information to guide treatment decisions for their patients.
Sources: Aranesp official site
Aranesp is known as one of Amgen's erythropoiesis-stimulating agents (ESAs) used specifically to manage anemia due to chronic kidney disease, marketed with a focus on clinical study backing for nephrologists.
Sources: Aranesp official site
Aranesp scores 31/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Aranesp has a weak AI-visibility profile at 31/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is trust (19/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 34/100 and thin schema.org structured data. In a live check, Claude could already identify Aranesp from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Aranesp: APOLLON Hochschule (69/100), Antares Foundation (69/100), Armor Dental (69/100), Arterys (69/100).
A step up - brands to learn from: ZT Corporate (71/100), Zorgnet-Icuro (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.